ArticleMolecular therapy. Methods & clinical development2023

Systemic γ-sarcoglycan AAV gene transfer results in dose-dependent correction of muscle deficits in the LGMD 2C/R5 mouse model.

Young-Eun Seo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.